hsa-miR-191

ncRNA information

ncRNA name

hsa-miR-191

Specific or universal ncRNAs

Specific ncRNAs

Class

MicroRNA

Biomarker

No

Biomarker application

Upstream regulatory factors

Not available

Downstream target

RXRA

Cancer information

Cancer name

Prostate Cancer

Cancer site

Prostate

Treatment information

Treatment type

Radiotherapy

Impact of wild-type ncRNA on radiotherapy resistance

Up

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Up

Number of patients

Not available

Male patients

Not available

Female patients

Not available

Age range and number

Not available

Research information

PMID

Description

That miR-191 promotes prostate cancer survival after radiotherapy, and highlights retinoids as a potential option to improve radiotherapy response.

Tissue resource

human prostate carcinoma cell lines DU145

human prostate carcinoma cell lines PC3

human prostate carcinoma cell lines DU145

human prostate carcinoma cell lines PC3

Experiment

qRT-PCR,Western blot


Institute

American Type Culture Collection

American Type Culture Collection

American Type Culture Collection

Country

USA

United States

Continent

North American

North Amercian